Cargando…
The implications of pharmacogenomics in oncology
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329749/ https://www.ncbi.nlm.nih.gov/pubmed/37431482 http://dx.doi.org/10.34172/bi.2023.27686 |
| _version_ | 1785070085279318016 |
|---|---|
| author | Latimer, Jean J. |
| author_facet | Latimer, Jean J. |
| author_sort | Latimer, Jean J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10329749 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Tabriz University of Medical Sciences (TUOMS Publishing Group) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103297492023-07-10 The implications of pharmacogenomics in oncology Latimer, Jean J. Bioimpacts Perspective Tabriz University of Medical Sciences (TUOMS Publishing Group) 2023 2023-05-01 /pmc/articles/PMC10329749/ /pubmed/37431482 http://dx.doi.org/10.34172/bi.2023.27686 Text en © 2023 The Author(s). https://creativecommons.org/licenses/by-nc/4.0/This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
| spellingShingle | Perspective Latimer, Jean J. The implications of pharmacogenomics in oncology |
| title | The implications of pharmacogenomics in oncology |
| title_full | The implications of pharmacogenomics in oncology |
| title_fullStr | The implications of pharmacogenomics in oncology |
| title_full_unstemmed | The implications of pharmacogenomics in oncology |
| title_short | The implications of pharmacogenomics in oncology |
| title_sort | implications of pharmacogenomics in oncology |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329749/ https://www.ncbi.nlm.nih.gov/pubmed/37431482 http://dx.doi.org/10.34172/bi.2023.27686 |
| work_keys_str_mv | AT latimerjeanj theimplicationsofpharmacogenomicsinoncology AT latimerjeanj implicationsofpharmacogenomicsinoncology |